Skip to main content
Top
Published in: Acta Diabetologica 5/2024

Open Access 08-02-2024 | Type 1 Diabetes | Original Article

Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry

Authors: Antonio Nicolucci, Giusi Graziano, Fortunato Lombardo, Ivana Rabbone, Maria Chiara Rossi, Giacomo Vespasiani, Stefano Zucchini, Riccardo Bonfanti, The ISPED CARD Study Group

Published in: Acta Diabetologica | Issue 5/2024

Login to get access

Abstract

Aim

In Italy, the ISPED CARD initiative was launched to measure and improve quality of care in children and adolescents with type 1 diabetes.

Methods

Process and outcome indicators and the related information derived from electronic medical records were identified. A network of pediatric diabetes centers was created on a voluntary basis.

Results

Overall, 20 centers provided data on 3284 patients aged <  = 18 years. HbA1c was monitored ≥ 2/year in 81.2% of the cases. BMI was monitored ≥ 1/year in 99.0%, lipid profile in 45.3%, and blood pressure in 91.7%. Pubertal status, albuminuria, eye examination, and screening of celiac disease and thyroiditis were underreported. From 2017 to 2021, average HbA1c levels decreased from 7.8 ± 1.2 to 7.6 ± 1.3%, while patients with LDL cholesterol > 100 mg/dl increased from 18.9 to 36.7%. Prevalence of patients with elevated blood pressure and BMI/SDS values also increased. In 2021, 44.7% of patients were treated with the newest basal insulins, while use of regular human insulin had dropped to 7.7%. Use of insulin pump remained stable (37.9%).

Conclusions

This report documents the feasibility of the ISPED CARD initiative and shows lights and shadows in the care provided. Improving care, increasing number of centers, and ameliorating data recording represent future challenges.
Appendix
Available only for authorised users
Literature
1.
go back to reference Delvecchio M, Mozzillo E, Salzano G et al (2017) Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab 102:1826–1834CrossRefPubMed Delvecchio M, Mozzillo E, Salzano G et al (2017) Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab 102:1826–1834CrossRefPubMed
2.
go back to reference Cherubini V (2003) RIDI: the registry of type 1 diabetes in Italy. Diabetes Nutr Metab 16:203–205PubMed Cherubini V (2003) RIDI: the registry of type 1 diabetes in Italy. Diabetes Nutr Metab 16:203–205PubMed
3.
go back to reference Carle F, Gesuita R, Bruno G et al (2004) Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care 27:2790–2796CrossRefPubMed Carle F, Gesuita R, Bruno G et al (2004) Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care 27:2790–2796CrossRefPubMed
4.
go back to reference Bruno G, Maule M, Merletti F et al (2010) Age-period-cohort analysis of 1990–2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes 59:2281–2287CrossRefPubMedPubMedCentral Bruno G, Maule M, Merletti F et al (2010) Age-period-cohort analysis of 1990–2003 incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes 59:2281–2287CrossRefPubMedPubMedCentral
6.
go back to reference Chiang JL, Maahs DM, Garvey KC et al (2018) Type 1 diabetes in children and adolescents: a position statement by the American diabetes association. Diabetes Care 41:2026–2044CrossRefPubMedPubMedCentral Chiang JL, Maahs DM, Garvey KC et al (2018) Type 1 diabetes in children and adolescents: a position statement by the American diabetes association. Diabetes Care 41:2026–2044CrossRefPubMedPubMedCentral
7.
go back to reference Bjornstad P, Dart A, Donaghue KC et al (2022) ISPAD clinical practice consensus guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes 23:1432–1450CrossRefPubMed Bjornstad P, Dart A, Donaghue KC et al (2022) ISPAD clinical practice consensus guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes 23:1432–1450CrossRefPubMed
8.
go back to reference Limbert C, Tinti D, Malik F et al (2022) ISPAD clinical practice consensus guidelines 2022: the delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes 23:1243–1269CrossRefPubMed Limbert C, Tinti D, Malik F et al (2022) ISPAD clinical practice consensus guidelines 2022: the delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes 23:1243–1269CrossRefPubMed
9.
go back to reference ElSayed NA, Aleppo G, Aroda VR et al (2023) 14. Children and adolescents: standards of care in diabetes-2023. Diabetes Care 46:S230–S253CrossRefPubMed ElSayed NA, Aleppo G, Aroda VR et al (2023) 14. Children and adolescents: standards of care in diabetes-2023. Diabetes Care 46:S230–S253CrossRefPubMed
11.
go back to reference McGee RG, Cowell CT, Arnolda G et al (2020) Assessing guideline adherence in the management of type 1 diabetes mellitus in Australian children: a population-based sample survey. BMJ Open Diabetes Res Care 8:e001141CrossRefPubMedPubMedCentral McGee RG, Cowell CT, Arnolda G et al (2020) Assessing guideline adherence in the management of type 1 diabetes mellitus in Australian children: a population-based sample survey. BMJ Open Diabetes Res Care 8:e001141CrossRefPubMedPubMedCentral
12.
go back to reference Selvin E, Narayan KMV, Huang ES. Quality of Care in People With Diabetes (2018) In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); CHAPTER 41. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568015/ Selvin E, Narayan KMV, Huang ES. Quality of Care in People With Diabetes (2018) In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); CHAPTER 41. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK568015/​
13.
go back to reference Rossi MC, Candido R, Ceriello A et al (2015) Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative. Acta Diabetol 52:557–571CrossRefPubMed Rossi MC, Candido R, Ceriello A et al (2015) Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative. Acta Diabetol 52:557–571CrossRefPubMed
14.
go back to reference Pintaudi B, Scatena A, Piscitelli G et al (2021) Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular risk: a multicenter, observational, retrospective study. Diabetes Res Clin Pract 182:109131CrossRefPubMed Pintaudi B, Scatena A, Piscitelli G et al (2021) Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular risk: a multicenter, observational, retrospective study. Diabetes Res Clin Pract 182:109131CrossRefPubMed
15.
go back to reference Rossi MC, Nicolucci A, Arcangeli A et al (2008) (2008) Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics. Diabetes Care 31:2166–2168CrossRefPubMedPubMedCentral Rossi MC, Nicolucci A, Arcangeli A et al (2008) (2008) Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics. Diabetes Care 31:2166–2168CrossRefPubMedPubMedCentral
16.
go back to reference Hayward RA, Hofer TP, Kerr EA, Krein SL (2004) Quality improvement initiatives: issues in moving from diabetes guidelines to policy. Diabetes Care 27(Suppl 2):B54-60CrossRefPubMed Hayward RA, Hofer TP, Kerr EA, Krein SL (2004) Quality improvement initiatives: issues in moving from diabetes guidelines to policy. Diabetes Care 27(Suppl 2):B54-60CrossRefPubMed
17.
go back to reference Jencks SF, Cuerdon T, Burwen DR et al (2000) Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA 284:1670–1676CrossRefPubMed Jencks SF, Cuerdon T, Burwen DR et al (2000) Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA 284:1670–1676CrossRefPubMed
18.
go back to reference Nicolucci A, Greenfield S, Mattke S (2006) Selecting indicators for the quality of diabetes care at the health systems level in OECD countries. Int J Qual Health Care 18(Suppl 1):26–30CrossRefPubMed Nicolucci A, Greenfield S, Mattke S (2006) Selecting indicators for the quality of diabetes care at the health systems level in OECD countries. Int J Qual Health Care 18(Suppl 1):26–30CrossRefPubMed
19.
go back to reference TRIAD Study Group (2002) The translating research into action for diabetes (TRIAD) study: a multicentre study of diabetes in managed care. Diabetes Care 25:386–389CrossRef TRIAD Study Group (2002) The translating research into action for diabetes (TRIAD) study: a multicentre study of diabetes in managed care. Diabetes Care 25:386–389CrossRef
20.
go back to reference Hofer SE, Schwandt A, Holl RW (2016) Standardized documentation in pediatric diabetology: experience from Austria and Germany. J Diabetes Sci Technol 10:1042–1049CrossRefPubMedPubMedCentral Hofer SE, Schwandt A, Holl RW (2016) Standardized documentation in pediatric diabetology: experience from Austria and Germany. J Diabetes Sci Technol 10:1042–1049CrossRefPubMedPubMedCentral
21.
go back to reference Danne T, Hanas R (2016) The mission of SWEET: harmonize care to optimize outcomes of children with diabetes worldwide. Pediatr Diabetes 17(Suppl 23):3–6CrossRefPubMed Danne T, Hanas R (2016) The mission of SWEET: harmonize care to optimize outcomes of children with diabetes worldwide. Pediatr Diabetes 17(Suppl 23):3–6CrossRefPubMed
22.
go back to reference Mungmode A, Noor N, Weinstock RS et al (2002) Making diabetes electronic medical record data actionable: promoting benchmarking and population health improvement using the T1D exchange quality improvement portal. Clin Diabetes 41:45–55CrossRef Mungmode A, Noor N, Weinstock RS et al (2002) Making diabetes electronic medical record data actionable: promoting benchmarking and population health improvement using the T1D exchange quality improvement portal. Clin Diabetes 41:45–55CrossRef
23.
go back to reference International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.
24.
go back to reference Gerhardsson P, Schwandt A, Witsch M et al (2021) The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther 23:491–499CrossRefPubMed Gerhardsson P, Schwandt A, Witsch M et al (2021) The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes. Diabetes Technol Ther 23:491–499CrossRefPubMed
25.
go back to reference Demeterco-Berggren C, Ebekozien O, Noor N et al (2022) Factors associated with achieving target alC in children and adolescents with type 1 diabetes: findings from the T1D exchange quality improvement collaborative. Clin Diabetes 41:68–75CrossRefPubMedPubMedCentral Demeterco-Berggren C, Ebekozien O, Noor N et al (2022) Factors associated with achieving target alC in children and adolescents with type 1 diabetes: findings from the T1D exchange quality improvement collaborative. Clin Diabetes 41:68–75CrossRefPubMedPubMedCentral
Metadata
Title
Continuous improvement of quality of care in pediatric diabetes: the ISPED CARD clinical registry
Authors
Antonio Nicolucci
Giusi Graziano
Fortunato Lombardo
Ivana Rabbone
Maria Chiara Rossi
Giacomo Vespasiani
Stefano Zucchini
Riccardo Bonfanti
The ISPED CARD Study Group
Publication date
08-02-2024
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-023-02233-6

Other articles of this Issue 5/2024

Acta Diabetologica 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine